CBRE is pleased to exclusively present for sale this mission-critical DaVita Dialysis facility located in Willow Grove, Pennsylvania. This location is one of the few DaVita centers in the Philadelphia MSA offering nocturnal dialysis in addition to standard treatments — a specialized and essential service that makes this site indispensable for local patient care. DaVita has operated at this location since 2010 under an original 15-year lease set to expire in 2025. In a recent lease amendment, the tenant committed to an additional 5-year term, now extending through November 2030. This early extension reflects DaVita’s long-term commitment to the site, plus Dialysis centers have a high renewal rate due to the significant regulatory, logistical, and clinical complexities involved in relocation. The lease features a rare and favorable rent structure, including a 5% increase in 2025 followed by 2.5% annual bumps throughout the remainder of the base term and renewal option — providing investors with built-in rent growth and long-term income stability. The lease is backed by DaVita Inc. (NYSE: DVA), a global leader in dialysis services with a network of almost 2,700 outpatient centers and a “BB” credit rating from Standard & Poor’s, offering investment-grade security and strong corporate backing. Ownership is passive and low-maintenance under a double net (NN) structure, with the tenant responsible for taxes, insurance, and CAM. The landlord is responsible only for the roof and structure. The 8,504 SF building was fully renovated in 2010 with all new systems and a new roof, which includes a transferable manufacturer’s warranty — significantly minimizing near-term capital expenditures.